Invitae Corporation (NVTA)
NYSE: NVTA · IEX Real-Time Price · USD
0.534
-0.006 (-1.18%)
At close: Nov 27, 2023, 4:00 PM
0.522
-0.012 (-2.23%)
Pre-market: Nov 28, 2023, 5:50 AM EST
Invitae Market Cap
Invitae has a market cap or net worth of $152.96 million as of November 28, 2023. Its market cap has decreased by -79.95% in one year.
Market Cap
152.96M
Enterprise Value
1.40B
1-Year Change
-79.95%
Ranking
Category
Stock Price
$0.53
Market Cap Chart
Since February 12, 2015, Invitae's market cap has decreased from $508.10M to $152.96M, a decrease of -69.90%. That is a compound annual growth rate of -12.77%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 24, 2023 | 154.70M | -0.58% |
Nov 22, 2023 | 155.60M | 4.22% |
Nov 21, 2023 | 149.30M | -7.78% |
Nov 20, 2023 | 161.90M | -2.41% |
Nov 17, 2023 | 165.90M | 6.62% |
Nov 16, 2023 | 155.60M | -1.46% |
Nov 15, 2023 | 157.90M | -8.14% |
Nov 14, 2023 | 171.90M | 16.07% |
Nov 13, 2023 | 148.10M | 9.95% |
Nov 10, 2023 | 134.70M | 11.97% |
Nov 9, 2023 | 120.30M | -39.06% |
Nov 8, 2023 | 197.40M | 8.11% |
Nov 7, 2023 | 182.60M | 2.35% |
Nov 6, 2023 | 178.40M | 5.19% |
Nov 3, 2023 | 169.60M | 0.83% |
Nov 2, 2023 | 168.20M | 9.36% |
Nov 1, 2023 | 153.80M | -4.94% |
Oct 31, 2023 | 161.80M | -0.31% |
Oct 30, 2023 | 162.30M | 5.87% |
Oct 27, 2023 | 153.30M | 1.46% |
Oct 26, 2023 | 151.10M | 10.13% |
Oct 25, 2023 | 137.20M | -5.57% |
Oct 24, 2023 | 145.30M | 2.25% |
Oct 23, 2023 | 142.10M | -4.63% |
Oct 20, 2023 | 149.00M | -8.53% |
View and export this data all the way back to 2015.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Allakos | 159.21M |
Verrica Pharmaceuticals | 159.00M |
Nutex Health | 158.98M |
PetMed Express | 158.60M |
Regencell Bioscience Holdings | 156.15M |
Greenwich LifeSciences | 153.79M |
Larimar Therapeutics | 153.67M |
Praxis Precision Medicines | 151.69M |